Infectious Disease: Clinical Trials

3 trials for Infectious Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3

Follow Infectious Disease: new trials by email Literature Review of Infectious Disease trials Research Report on Infectious Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression
Tafenoquine Oral Tablet, Placebo - COVID 19 Disease, Mild to Moderate COVID 19 Disease
Phase 2Unknown60P Australia Pty Ltd1482023-08-012023-07-17
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever
Phase 2UnknownSingapore General Hospital702022-09-282023-04-12
A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers
NU300, ActHIB, Prevnar 13 - Infectious Disease
Phase 2UnknownNuron Biotech Inc.2202013-03-012013-09-23

Narrower conditions

Communicable Diseases (3)  ·  Encephalitis, Japanese (1)  ·  Virus Diseases (1)  ·  Yellow Fever (1)

Broader conditions

Disease Attributes (3)  ·  Infections (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arbovirus Infections (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  Encephalitis (1)  ·  Encephalitis, Arbovirus (1)  ·  Encephalitis, Viral (1)  ·  Flaviviridae Infections (1)  ·  Flavivirus Infections (1)  ·  Hemorrhagic Fevers, Viral (1)

Interventions

13-valent pneumococcal vaccine (1)  ·  Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1)  ·  tafenoquine (1)

Sponsors

60P Australia Pty Ltd (1)  ·  Nuron Biotech Inc. (1)  ·  Singapore General Hospital (1)

Countries

Singapore (1)  ·  United States (1)

Top investigators

Shirin Kalimuddin, MRCP (UK) (1)

Results publications

PMID 30519584, PMID 32382733, PMID 33333292, PMID 33820486, PMID 35101449, PMID 35668841, PMID 35713893, PMID 36969244, PMID 39794472, PMID 9598455